Goodman, Corey S.

Goodman, Corey S.

Affiliated Entities 14ner Oncology, Inc. Adelman Robert J Akero Therapeutics, Inc. Alx Oncology Holdings Inc Artiva Biotherapeutics, Inc. Checkmate Pharmaceuticals, Inc. Impel Neuropharma Inc. Metacrine, Inc. Pfizer, Inc. Precision Biosciences, Inc. RayzeBio, Inc. Renovis, Inc. Royston Aaron venBio Global Strategic Fund II L.P. venBio Global Strategic Fund III, L.P. Venbio Global Strategic Fund LP venBio Global Strategic GP II, L.P. venBio Global Strategic GP II, Ltd. Venbio Global Strategic Gp III, Ltd Venbio Global Strategic Gp Ltd.         venBio Global Strategic GP, L.P.

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

Filter By From To

	Date Filed	Venue	Case Number	Title	Party Type
	11/6/2002	United States Patent and Trademark Office	10289776	Modulating Robo: Ligand Interactions	Applicant
	2/4/2002	United States Patent and Trademark Office	10067632	Semaphorin Gene Family	Applicant
	8/3/2001	United States Patent and Trademark Office	09922600	Modulating robo:ligand interactions	Applicant
	11/13/1998	United States Patent and Trademark Office	09191647	Modulating Robo: Ligand Interactions	Applicant
	11/13/1998	United States Patent and Trademark Office	09191651	Method For Modulating Nerve Cell Function	Applicant
	4/15/1998	United States Patent and Trademark Office	09060610	Semaphorin - Specific Antibodies	Applicant
	4/15/1998	United States Patent and Trademark Office	09060692	Semaphorin Gene Family	Applicant
	11/14/1997	United States Patent and Trademark Office	08971172	Robo: A Novel Family Of Polypeptides And Nucleic Acids	Applicant
	4/8/1997	United States Patent and Trademark Office	08833391	Semaphorin Gene Family	Applicant
	4/8/1997	United States Patent and Trademark Office	08835268	Semaphorin Gene Family	Applicant
	9/13/1993	United States Patent and Trademark Office	08121713	Semaphorin Gene Family	Applicant

11 Rows Total

Outside Counsel (265)

	Last Name	First Name	Middle Name	Firm	Location
	Heines	M.	Henry	Stauffer Chemical Company
	Henderson	Mymy		Kilpatrick Townsend & Stockton, LLP
	Hetzer-egger	Claudia	H.	Kilpatrick Townsend & Stockton, LLP	San Diego, CA
	Hindman	Matthew		Kilpatrick Townsend & Stockton, LLP
	Hinsch.	Matthew	E.	Kilpatrick Townsend & Stockton, LLP
	Hokamura	Aaron		Kilpatrick Townsend & Stockton, LLP
	Hollister	Matthew	A.	Kilpatrick Townsend & Stockton, LLP	DENVER, CO
	Holloway	David	Clayton	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Holmes	Brenda	Ozaki	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Holt	Benjamin		Kilpatrick Townsend & Stockton, LLP
	Hopkins	Mark	H.	Kilpatrick Townsend & Stockton, LLP
	Howard	James		Kilpatrick Townsend & Stockton, LLP
	Hsu	Richard		Kilpatrick Townsend & Stockton, LLP
	Hsueh	Hain-Whei		Kilpatrick Townsend & Stockton, LLP
	Hunter	Shane	H.	Kilpatrick Townsend & Stockton, LLP
	Hylton	Roger		Kilpatrick Townsend & Stockton, LLP
	Jarvis	Peter	M.	Kilpatrick Townsend & Stockton, LLP	DENVER, CO
	Jarvis	Peter		Sharp Kabushiki Kaisha
	Jenkins	Kenneth	E.	Kilpatrick Townsend & Stockton, LLP
	Jensen	Philip		Kilpatrick Townsend & Stockton, LLP
	Jewett	Stephen	F.	Kilpatrick Townsend & Stockton, LLP
	Jewik	Patrick	R.	Leydig Voit & Mayer, Ltd.	WASHINGTON, DC
	Johns	Athena	C.	Kilpatrick Townsend & Stockton, LLP
	Johns.	Carol	P.	Kilpatrick Townsend & Stockton, LLP
	Johnson	Frank		Kilpatrick Townsend & Stockton, LLP
	Joswick	Eugene	B.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Kadaba	Vaibhav	P.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Kamlay	Aaron		Kilpatrick Townsend & Stockton, LLP
	KAO	DAH-BIN		Kilpatrick Townsend & Stockton, LLP
	Karkhanis	Aashish		Kilpatrick Townsend & Stockton, LLP
	Karrar	Adil		Kilpatrick Townsend & Stockton, LLP
	Kezer	William	B.	Kilpatrick Townsend & Stockton, LLP
	Kleinman-Green	Benjamin	Max	Kilpatrick Townsend & Stockton, LLP
	Knittel	Marc	R.	Kilpatrick Townsend & Stockton, LLP
	Koerber	Steven	C.	Kilpatrick Townsend & Stockton, LLP	San Diego, CA
	Kolassa	Scott	E.	Kilpatrick Townsend & Stockton, LLP
	Korn	Russell	Adam	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Korsh	George		Kilpatrick Townsend & Stockton, LLP
	Kotwal	Sujit	B.	Kilpatrick Townsend & Stockton, LLP	San Francisco, CA
	Kulikowski	Konrad	J.	Kilpatrick Townsend & Stockton, LLP
	Kurlancheek	Dara	M.	Kilpatrick Townsend & Stockton, LLP	Washington, DC
	Kusha	Babak		Kilpatrick Townsend & Stockton, LLP	San Francisco, CA
	Kwan	Jordan		Kilpatrick Townsend & Stockton, LLP
	Lambert	William		Kilpatrick Townsend & Stockton, LLP
	Lane	William		Kilpatrick Townsend & Stockton, LLP
	Largent	Craig	C.	Kilpatrick Townsend & Stockton, LLP	Menlo Park, CA
	Lee	Andrew	Jung-min	Kilpatrick Townsend & Stockton, LLP
	Lee	Joshua	H.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Leroy	Rodney	D.	Kilpatrick Townsend & Stockton, LLP
	Lezak	Arrienne		Kilpatrick Townsend & Stockton, LLP
	Li	Chia-Chi		Kilpatrick Townsend & Stockton, LLP
	LIEBESCHUETZ	JOE		Kilpatrick Townsend & Stockton, LLP	SAN FRANCICCO, CA
	Lindemann	John		Kilpatrick Townsend & Stockton, LLP	Ca,
	Link	James	Jason	Kilpatrick Townsend & Stockton, LLP	WINSTON-SALEM, NC
	Link	Jonathan	Dyste	Kilpatrick Townsend & Stockton, LLP	Washington, DC
	Lockyer.	Jean	M.	Kilpatrick Townsend & Stockton, LLP	San Francisco, CA
	Lohr.	Jason	D.	Kilpatrick Townsend & Stockton, LLP
	Loos	Brad	J.	Kilpatrick Townsend & Stockton, LLP
	M.HESLIN	JAMES		Kilpatrick Townsend & Stockton, LLP	San Francisco, CA
	Malhotra	Reena		Kilpatrick Townsend & Stockton, LLP
	Mathison	Mark	Philip	Kilpatrick Townsend & Stockton, LLP
	McCarthy	Neil		Knobbe Martens Olson & Bear LLP
	Mccormick	Daniel	K.	Kilpatrick Townsend & Stockton, LLP
	McCoy	Megan		Kilpatrick Townsend & Stockton, LLP
	McDonald	John		Kilpatrick Townsend & Stockton, LLP
	McGroarty	John		Kilpatrick Townsend & Stockton, LLP
	McKeon	Tina	Williams	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	McMaster	Mark	Thomas	Kilpatrick Townsend & Stockton, LLP	Seattle, WA
	McMillan	Scott		Kilpatrick Townsend & Stockton, LLP	DENVER, CO
	Meyer	Richard	S.	Kilpatrick Townsend & Stockton, LLP	Washington, DC
	Minsk	Alan	D.	Limbach & Limbach, LLP
	Mixon	Shelley		Kilpatrick Townsend & Stockton, LLP
	Morlock	Michael	T.	Kilpatrick Townsend & Stockton, LLP	Winston-salem, Nc,
	Morris	Gary	S.	Kenyon & Kenyon, LLP
	Mycroft	Francis		Kilpatrick Townsend & Stockton, LLP
	Nezam	Yama		Kilpatrick Townsend & Stockton, LLP
	Nomura	Anson	M.	Kilpatrick Townsend & Stockton, LLP	San Diego, CA
	O'Reilly	Shayne		Kilpatrick Townsend & Stockton, LLP
	Oliver	Andrew	T.	Kilpatrick Townsend & Stockton, LLP	Palo Alto, CA
	Olsen	Kindon		Kilpatrick Townsend & Stockton, LLP
	Osman	Richard		RICHARD ARON OSMAN
	Ostomel.	Todd	A.	Kilpatrick Townsend & Stockton, LLP
	Pacheco	Raquel		Kilpatrick Townsend & Stockton, LLP	Ca,
	Pagar	Preetam	B.	Kilpatrick Townsend & Stockton, LLP
	Parent	Annette	S.	Morgan, Lewis & Bockius, LLP	San Francisco, CA
	Parmelee	Steven	W.	Kilpatrick Townsend & Stockton, LLP	San Francisco, CA
	Parmenter.	Sean	F.	Kilpatrick Townsend & Stockton, LLP
	Patterson	Melissa		Kilpatrick Townsend & Stockton, LLP
	Pavento	Michael	Samuel	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Peterson	Rebecca		Kilpatrick Townsend & Stockton, LLP
	Polovnikova	Elena		Kilpatrick Townsend & Stockton, LLP
	Portnow	Douglas		Wilson Sonsini Goodrich & Rosati, PC
	Powell	N..		Kilpatrick Townsend & Stockton, LLP
	Pratt	John	S.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Presley	Andrew	David	Kilpatrick Townsend & Stockton, LLP	San Francisco, CA
	Pyonin	Adam	J.	Kilpatrick Townsend & Stockton, LLP
	Raczkowski	David	R.	Kilpatrick Townsend & Stockton, LLP
	Raskin	Vladimir		Kilpatrick Townsend & Stockton, LLP
	Reed	David	Alan	Kilpatrick Townsend & Stockton, LLP	ATLANTA, GA
	Reed	David		Sharp Kabushiki Kaisha

265 Rows Total	Page 2 of 3 | Go To

Filter By Form All Records 3 4 From To

	Date	Entity	Form Number	Description
	1/23/2025	Alx Oncology Holdings Inc	4	Statement of changes in beneficial ownership of securities
	7/22/2024	Artiva Biotherapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	7/18/2024	Artiva Biotherapeutics, Inc.	3	Initial statement of beneficial ownership of securities
	6/14/2024	Alx Oncology Holdings Inc	4	Statement of changes in beneficial ownership of securities
	9/21/2023	RayzeBio, Inc.	4	Statement of changes in beneficial ownership of securities
	9/14/2023	RayzeBio, Inc.	3	Initial statement of beneficial ownership of securities
	6/22/2023	Alx Oncology Holdings Inc	4	Statement of changes in beneficial ownership of securities
	6/16/2022	Alx Oncology Holdings Inc	4	Statement of changes in beneficial ownership of securities
	6/10/2022		4	Statement of changes in beneficial ownership of securities
	5/27/2022	14ner Oncology, Inc.	4	Statement of changes in beneficial ownership of securities
	5/17/2022	Checkmate Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	5/12/2022	Checkmate Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	5/9/2022	Checkmate Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	5/4/2022	Checkmate Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	4/29/2022	Checkmate Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	4/26/2022	Checkmate Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	4/21/2022	Checkmate Pharmaceuticals, Inc.	4	Statement of changes in beneficial ownership of securities
	10/26/2021	Metacrine, Inc.	4	Statement of changes in beneficial ownership of securities
	10/25/2021		4	Statement of changes in beneficial ownership of securities
	10/20/2021		3	Initial statement of beneficial ownership of securities
	7/1/2021	14ner Oncology, Inc.	4	Statement of changes in beneficial ownership of securities
	6/24/2021		3	Initial statement of beneficial ownership of securities
	6/15/2021	Alx Oncology Holdings Inc	4	Statement of changes in beneficial ownership of securities
	4/29/2021	Impel Neuropharma Inc.	4	Statement of changes in beneficial ownership of securities
	4/26/2021	Impel Neuropharma Inc.	4	Statement of changes in beneficial ownership of securities
	4/22/2021	Impel Neuropharma Inc.	3	Initial statement of beneficial ownership of securities
	9/22/2020	Venbio Global Strategic Fund LP	4	Statement of changes in beneficial ownership of securities
	9/15/2020	Venbio Global Strategic Fund LP	3	Initial statement of beneficial ownership of securities
	8/12/2020	venBio Global Strategic Fund II L.P.	4	Statement of changes in beneficial ownership of securities
	8/6/2020	venBio Global Strategic Fund II L.P.	3	Initial statement of beneficial ownership of securities
	7/21/2020	Alx Oncology Holdings Inc	4	Statement of changes in beneficial ownership of securities
	7/17/2020	Alx Oncology Holdings Inc	4	Statement of changes in beneficial ownership of securities
	7/16/2020	Alx Oncology Holdings Inc	3	Initial statement of beneficial ownership of securities
	7/6/2020	venBio Global Strategic Fund II L.P.	4	Statement of changes in beneficial ownership of securities
	3/6/2020	venBio Global Strategic Fund II L.P.	4	Statement of changes in beneficial ownership of securities
	3/3/2020	Akero Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	2/27/2020	venBio Global Strategic Fund II L.P.	4	Statement of changes in beneficial ownership of securities
	2/12/2020	venBio Global Strategic Fund II L.P.	4	Statement of changes in beneficial ownership of securities
	2/10/2020	Akero Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	2/6/2020	venBio Global Strategic Fund II L.P.	4	Statement of changes in beneficial ownership of securities
	1/14/2020	venBio Global Strategic Fund II L.P.	4	Statement of changes in beneficial ownership of securities
	1/10/2020	venBio Global Strategic Fund II L.P.	4	Statement of changes in beneficial ownership of securities
	1/8/2020	venBio Global Strategic Fund II L.P.	4	Statement of changes in beneficial ownership of securities
	1/6/2020	Akero Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	1/3/2020	venBio Global Strategic Fund II L.P.	4	Statement of changes in beneficial ownership of securities
	6/25/2019	venBio Global Strategic Fund II L.P.	4	Statement of changes in beneficial ownership of securities
	6/19/2019	venBio Global Strategic Fund II L.P.	3	Initial statement of beneficial ownership of securities
	4/1/2019	Precision Biosciences, Inc.	4	Statement of changes in beneficial ownership of securities
	3/27/2019	Venbio Global Strategic Fund LP	3	Initial statement of beneficial ownership of securities
	5/1/2009	Pfizer, Inc.	4	Statement of changes in beneficial ownership of securities

117 Rows Total	Page 1 of 3 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	11/9/2004	Renovis, Inc.	Assignee	Application Publication	10736460 20040167226	Methods for the treatment of pain and traumatic injury using benzamides ... Methods for the treatment of pain and traumatic injury using benzamides ...
	4/30/2004	Renovis, Inc.	Assignee	Application Publication	10736460 20040167226	Methods for the treatment of pain and traumatic injury using benzamides ... Methods for the treatment of pain and traumatic injury using benzamides ...
	11/6/2002	Howard Hughes Medical Institute	Assignee	Application Publication Patent	10289776 20030170727 6861228	Modulating Robo: Ligand Interactions Modulating Robo: Ligand Interactions Modulating Robo: Ligand Interactions
	2/4/2002	Regents Of The University Of California	Assignee	Application Publication Patent	10067632 20030166849 7153936	Semaphorin Gene Family Semaphorin Gene Family Semaphorin Gene Family
	6/13/2000	Howard Hughes Medical Institute	Assignee	Application Patent	09540153 6270995	Recombinant Polynucleotides Encoding A Slit Polypeptide Recombinant Polynucleotides Encoding A Slit Polypeptide
	3/31/2000	Howard Hughes Medical Institute	Assignee	Application Patent	09540245 6270984	Modulating robo: ligand interactions Modulating robo: ligand interactions
	3/31/2000	Howard Hughes Medical Institute	Assignee	Application Patent	09540153 6270995	Recombinant Polynucleotides Encoding A Slit Polypeptide Recombinant Polynucleotides Encoding A Slit Polypeptide
	4/26/1999	Howard Hughes Medical Institute	Assignee	Application Patent	09191651 7005411	Method For Modulating Nerve Cell Function Method For Modulating Nerve Cell Function
	2/16/1999	Howard Hughes Medical Institute	Assignee	Application Patent	09191651 7005411	Method For Modulating Nerve Cell Function Method For Modulating Nerve Cell Function
	12/13/1993	Regents Of The University Of California	Assignee	Application Patent	08121713 5639856	Semaphorin Gene Family Semaphorin Gene Family

10 Rows Total

Goodman, Corey S. has not been involved in any trademark assignment transactions in the PlainSite database.

Affiliated Entities

• 14ner Oncology, Inc.
• Adelman Robert J
• Akero Therapeutics, Inc.
• Alx Oncology Holdings Inc
• Artiva Biotherapeutics, Inc.
• Checkmate Pharmaceuticals, Inc.
• Impel Neuropharma Inc.
• Metacrine, Inc.
• Pfizer, Inc.
• Precision Biosciences, Inc.
• RayzeBio, Inc.
• Renovis, Inc.
• Royston Aaron
• venBio Global Strategic Fund II L.P.
• venBio Global Strategic Fund III, L.P.
• Venbio Global Strategic Fund LP
• venBio Global Strategic GP II, L.P.
• venBio Global Strategic GP II, Ltd.
• Venbio Global Strategic Gp III, Ltd
• Venbio Global Strategic Gp Ltd.
• venBio Global Strategic GP, L.P.

Incoming Payments

This individual has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This individual has not disclosed any outgoing payments to lobbying groups.